GlaxoSmithKline Australia Pty Ltd—Children's Panadol Syringe

PRA number


Published date

Product description

Children’s Panadol Baby Drops Syringe dosing device provided with Children's Panadol 1 month to 2 years
Identifying features
All batches may potentially be affected

Other identifying numbers

All batches may potentially be affected

Reasons the product is recalled

The syringe may display incorrect dosage indicators.

The hazards to consumers

If the incorrect dosage is given to a child it may result in illness.

What consumers should do

Consumers should check syringes to determine whether they are affected. If you are uncertain whether your syringe is affected, please consult your pharmacist. If the syringe is incorrect, it should be returned to the pharmacy or call the GSK Product Information line on 1800 650 123.

If you have any concerns that your child may have received too much Children’s Panadol®, or if an overdose is taken or suspected, ring the Poisons Information Centre (Australia131 126) or go to the hospital immediately, even if your child feels well. There is a risk of delayed, serious liver damage if left untreated.


GlaxoSmithKline Australia Pty Ltd

Traders who sold this product

Various pharmacies nationwide

Where the product was sold


Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category

Is this page useful?